Literature DB >> 15499613

Tyrosine phosphorylation of PYK2 mediates heregulin-induced glioma invasion: novel heregulin/HER3-stimulated signaling pathway in glioma.

Edward Htun van der Horst1, Igor Weber, Axel Ullrich.   

Abstract

Receptor tyrosine kinases of the EGFR family transmit extracellular signals that control diverse cellular functions such as proliferation, differentiation and survival. Signaling function of a member of this family, HER3, is believed to be impaired due to deviations in its kinase consensus motifs. Here we address the functional role and signaling mechanisms of HER3. HER3 preferentially forms heterodimers with HER2 inducing the most potent mitogenic signal among EGFR family members. Our data show that in a glioma-derived cell line the cytoplasmic tyrosine kinase PYK2 is constitutively associated with HER3 and that stimulation with Heregulin results in PYK2 tyrosine phosphorylation. HER3, but not HER2, mediates the phosphorylation of the C-terminal region of PYK2 to promote a mitogenic response through activation of the MAPK pathway. A central role of PYK2 in signaling downstream of HER3 is substantiated by the demonstration that expression of a dominant-negative PYK2-KM construct abrogates the Heregulin-induced MAPK activity and inhibits the invasive potential of glioma cells. These results suggest a novel Heregulin/HER3-stimulated signaling pathway in glioblastoma-derived cell lines that involves phosphorylation of PYK2 and mediates invasiveness of glioma cells. (c) 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15499613     DOI: 10.1002/ijc.20643

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  18 in total

1.  Inhibition of doxorubicin-induced HER3-PI3K-AKT signalling enhances apoptosis of ovarian cancer cells.

Authors:  Martin Bezler; Jan G Hengstler; Axel Ullrich
Journal:  Mol Oncol       Date:  2012-07-20       Impact factor: 6.603

2.  Prediction of functional phosphorylation sites by incorporating evolutionary information.

Authors:  Shen Niu; Zhen Wang; Dongya Ge; Guoqing Zhang; Yixue Li
Journal:  Protein Cell       Date:  2012-07-16       Impact factor: 14.870

3.  Chemotherapy targeting by DNA capture in viral protein particles.

Authors:  Hasmik Agadjanian; David Chu; Jae Youn Hwang; Sebastian Wachsmann-Hogiu; Altan Rentsendorj; Lei Song; Vinod Valluripalli; Jay Lubow; Jun Ma; Behrooz Sharifi; Daniel L Farkas; Lali K Medina-Kauwe
Journal:  Nanomedicine (Lond)       Date:  2012-03       Impact factor: 5.307

4.  Effects of silibinin on growth and invasive properties of human ovarian carcinoma cells through suppression of heregulin/HER3 pathway.

Authors:  Majid Momeny; Reza Ghasemi; Giovanni Valenti; Mariska Miranda; Ali Zekri; Ghazaleh Zarrinrad; Sepehr Javadikooshesh; Marjan Yaghmaie; Kamran Alimoghaddam; Ardeshir Ghavamzadeh; Seyed H Ghaffari
Journal:  Tumour Biol       Date:  2015-10-19

5.  A mechanistic study of tumor-targeted corrole toxicity.

Authors:  Jae Youn Hwang; Jay Lubow; David Chu; Jun Ma; Hasmik Agadjanian; Jessica Sims; Harry B Gray; Zeev Gross; Daniel L Farkas; Lali K Medina-Kauwe
Journal:  Mol Pharm       Date:  2011-10-25       Impact factor: 4.939

6.  STRUBBELIG defines a receptor kinase-mediated signaling pathway regulating organ development in Arabidopsis.

Authors:  David Chevalier; Martine Batoux; Lynette Fulton; Karen Pfister; Ram Kishor Yadav; Maja Schellenberg; Kay Schneitz
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-10       Impact factor: 11.205

7.  Metastatic properties and genomic amplification of the tyrosine kinase gene ACK1.

Authors:  Edward Htun van der Horst; Yan Y Degenhardt; Astrid Strelow; Anthony Slavin; Lawrence Chinn; Jessica Orf; Minqing Rong; Shyun Li; Lei-Hoon See; Ken Q C Nguyen; Timothy Hoey; Holger Wesche; Scott Powers
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-24       Impact factor: 11.205

8.  TROY (TNFRSF19) is overexpressed in advanced glial tumors and promotes glioblastoma cell invasion via Pyk2-Rac1 signaling.

Authors:  Vincent M Paulino; Zhongbo Yang; Jean Kloss; Matthew J Ennis; Brock A Armstrong; Joseph C Loftus; Nhan L Tran
Journal:  Mol Cancer Res       Date:  2010-09-29       Impact factor: 5.852

9.  The Pyk2 FERM domain as a target to inhibit glioma migration.

Authors:  Joseph C Loftus; Zhongbo Yang; Nhan L Tran; Jean Kloss; Carole Viso; Michael E Berens; Christopher A Lipinski
Journal:  Mol Cancer Ther       Date:  2009-06-09       Impact factor: 6.261

10.  Cell aggregation induces phosphorylation of PECAM-1 and Pyk2 and promotes tumor cell anchorage-independent growth.

Authors:  Xing Zhang; Li-hua Xu; Qiang Yu
Journal:  Mol Cancer       Date:  2010-01-14       Impact factor: 27.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.